Related Experiment Videos
[Treatment of motor restlessness in children]
Psychiatrie, Neurologie Und Medizinische Psychologie. Beihefte
|January 1, 1975
Insights
Long-term pharmacotherapy and tailored interventions are crucial for treating hypermotility and erethism. Individualized treatment plans are essential, considering the child
Area of Science:
- Pediatrics
- Child Psychology
- Pharmacology
Context:
- Hypermotility and erethism in children present complex treatment challenges.
- Current approaches necessitate long-term, individualized pharmacotherapy.
Purpose:
- To outline the essential components of a comprehensive treatment strategy for hypermotility and erethism.
- To emphasize the need for personalized pharmacotherapy and multimodal interventions.
Summary:
- Effective treatment requires long-term pharmacotherapy, with dosages determined by individual factors like etiology, age, and physical constitution.
- Psychological, psychotherapeutic, sociotherapeutic, and pedagogical measures are integral to managing hypermotile behavior patterns.
Impact:
- Highlights the necessity of a holistic and individualized approach in pediatric behavioral management.
- Informs clinicians on the multifaceted nature of treating childhood hypermotility and erethism.
Abstract:
It is evident that the treatment of a condition of hypermotility and erethism demand a long-term, individually-suited pharmacotherapy. The question of dosage has been left out intentionally, since this must be determined very individually and dependent upon the child's etiology, age group, intellectual capabilities and his general physical constitution. Many-sided psychagoical, psycho- and sociotherapeutic and pedagogical measures also form part of the complex-treatment of a hypermotile pattern of behaviour.